Colin Hill is Chairman, CEO and Co-Founder of GNS Healthcare, a leading AI-driven precision medicine company.
Hill is a leading voice in healthcare technology and precision medicine. In 2016, Hill was appointed by Massachusetts Governor Charlie Baker to the Massachusetts Digital Health Council, having previously been appointed to the Board of Directors of the Center for Health Information and Analysis.
Hill is a founding board member of Transforming Medicine: The Elizabeth Kauffman Institute, a non-profit foundation (501c3) dedicated to the advancement of personalized medicine. He was a founding member of the Board of Directors of AesRx, a biopharmaceutical company dedicated to the development of new treatments for sickle cell disease (acquired by Baxter in 2014).
Hill holds a degree in Physics from Virginia Tech and Master’s degrees in Physics from both McGill University and Cornell University.
